FDA Inspection 918373 — Zhejiang Xianju Junye Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Xianju Junye Pharmaceutical Co., Ltd. on Feb 13, 2015 in Taizhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 13, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou (China)